SummerHaven Investment Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-90,158
Closed -$767K 286
2024
Q2
$767K Buy
90,158
+1,772
+2% +$15.8K 0.5% 101
2024
Q1
$930K Buy
88,386
+877
+1% +$9.74K 0.58% 62
2023
Q4
$909K Buy
87,509
+1,199
+1% +$9.55K 0.58% 56
2023
Q3
$547K Buy
+86,310
New +$637K 0.4% 170

Other funds holding ZYME

SummerHaven Investment Management's ZYME Position: Q3 2024 in Review

SummerHaven Investment Management sold out of Zymeworks (ZYME) in Q3 2024, closing a stake of 90,158 shares — an estimated $767K sold.

SummerHaven Investment Management first reported a position in ZYME in Q3 2023 and held it in 4 quarters. The position peaked at $930K in Q1 2024. 163 funds tracked by Wall St. Rank hold ZYME as of Q3 2024.

  • SummerHaven Investment Management reported no remaining Zymeworks position as of Q3 2024 after selling out during the quarter.
  • SummerHaven Investment Management sold 90,158 Zymeworks shares in Q3 2024, an estimated $767K.
  • SummerHaven Investment Management first reported a position in Zymeworks in Q3 2023 and held it in 4 quarters.
  • SummerHaven Investment Management's Zymeworks position peaked at $930K in Q1 2024.
  • 163 funds tracked by Wall St. Rank held Zymeworks as of Q3 2024.

Based on SummerHaven Investment Management's 13F filing for Q3 2024, filed 16 Oct 2024.